1043 related articles for article (PubMed ID: 27353492)
21. Vitamin D3 supplementation and body composition in persons with obesity and type 2 diabetes in the UAE: A randomized controlled double-blinded clinical trial.
Sadiya A; Ahmed SM; Carlsson M; Tesfa Y; George M; Ali SH; Siddieg HH; Abusnana S
Clin Nutr; 2016 Feb; 35(1):77-82. PubMed ID: 25892603
[TBL] [Abstract][Full Text] [Related]
22. The effect of high-dose vitamin D supplementation on insulin resistance and arterial stiffness in patients with type 2 diabetes.
Ryu OH; Chung W; Lee S; Hong KS; Choi MG; Yoo HJ
Korean J Intern Med; 2014 Sep; 29(5):620-9. PubMed ID: 25228838
[TBL] [Abstract][Full Text] [Related]
23. Effects of dapagliflozin and n-3 carboxylic acids on non-alcoholic fatty liver disease in people with type 2 diabetes: a double-blind randomised placebo-controlled study.
Eriksson JW; Lundkvist P; Jansson PA; Johansson L; Kvarnström M; Moris L; Miliotis T; Forsberg GB; Risérus U; Lind L; Oscarsson J
Diabetologia; 2018 Sep; 61(9):1923-1934. PubMed ID: 29971527
[TBL] [Abstract][Full Text] [Related]
24. The effects of resveratrol supplementation on cardiovascular risk factors in patients with non-alcoholic fatty liver disease: a randomised, double-blind, placebo-controlled study.
Faghihzadeh F; Adibi P; Hekmatdoost A
Br J Nutr; 2015 Sep; 114(5):796-803. PubMed ID: 26234526
[TBL] [Abstract][Full Text] [Related]
25. The association of serum FGF23 and non-alcoholic fatty liver disease is independent of vitamin D in type 2 diabetes patients.
He X; Shen Y; Ma X; Ying L; Peng J; Pan X; Bao Y; Zhou J
Clin Exp Pharmacol Physiol; 2018 Jul; 45(7):668-674. PubMed ID: 29574933
[TBL] [Abstract][Full Text] [Related]
26. The effect of co supplementation of omega-3 and vitamin D on cardio metabolic risk factors and psychological distress in reproductive-aged women with prediabetes and hypovitaminosis D: a study protocol for a randomized controlled trial.
Rajabi-Naeeni M; Dolatian M; Qorbani M; Vaezi AA
Trials; 2019 Dec; 20(1):799. PubMed ID: 31888762
[TBL] [Abstract][Full Text] [Related]
27. Glucose homeostasis, insulin resistance and inflammatory biomarkers in patients with non-alcoholic fatty liver disease: Beneficial effects of supplementation with microalgae Chlorella vulgaris: A double-blind placebo-controlled randomized clinical trial.
Ebrahimi-Mameghani M; Sadeghi Z; Abbasalizad Farhangi M; Vaghef-Mehrabany E; Aliashrafi S
Clin Nutr; 2017 Aug; 36(4):1001-1006. PubMed ID: 27475283
[TBL] [Abstract][Full Text] [Related]
28. Efficacy of vitamin D
Sudfeld CR; Mugusi F; Aboud S; Nagu TJ; Wang M; Fawzi WW
Trials; 2017 Feb; 18(1):66. PubMed ID: 28183335
[TBL] [Abstract][Full Text] [Related]
29. The relationship between 25-hydroxyvitamin D concentration and liver enzymes in overweight or obese adults: Cross-sectional and interventional outcomes.
Naderpoor N; Mousa A; de Courten M; Scragg R; de Courten B
J Steroid Biochem Mol Biol; 2018 Mar; 177():193-199. PubMed ID: 28899715
[TBL] [Abstract][Full Text] [Related]
30. Long-term effects of vitamin D supplementation in vitamin D deficient obese children participating in an integrated weight-loss programme (a double-blind placebo-controlled study) - rationale for the study design.
Szlagatys-Sidorkiewicz A; Brzeziński M; Jankowska A; Metelska P; Słomińska-Frączek M; Socha P
BMC Pediatr; 2017 Apr; 17(1):97. PubMed ID: 28376768
[TBL] [Abstract][Full Text] [Related]
31. The effects of vitamin D
Esfandiari A; Pourghassem Gargari B; Noshad H; Sarbakhsh P; Mobasseri M; Barzegari M; Arzhang P
Diabetes Metab Syndr; 2019; 13(1):278-283. PubMed ID: 30641712
[TBL] [Abstract][Full Text] [Related]
32. Vitamin D supplementation in obese type 2 diabetes subjects in Ajman, UAE: a randomized controlled double-blinded clinical trial.
Sadiya A; Ahmed SM; Carlsson M; Tesfa Y; George M; Ali SH; Siddieg HH; Abusnana S
Eur J Clin Nutr; 2015 Jun; 69(6):707-11. PubMed ID: 25406966
[TBL] [Abstract][Full Text] [Related]
33. Vitamin D3 supplementation: Response and predictors of vitamin D3 metabolites - A randomized controlled trial.
Lehmann U; Riedel A; Hirche F; Brandsch C; Girndt M; Ulrich C; Seibert E; Henning C; Glomb MA; Dierkes J; Stangl GI
Clin Nutr; 2016 Apr; 35(2):351-358. PubMed ID: 26037521
[TBL] [Abstract][Full Text] [Related]
34. The effects of vitamin D and probiotic co-supplementation on mental health parameters and metabolic status in type 2 diabetic patients with coronary heart disease: A randomized, double-blind, placebo-controlled trial.
Raygan F; Ostadmohammadi V; Bahmani F; Asemi Z
Prog Neuropsychopharmacol Biol Psychiatry; 2018 Jun; 84(Pt A):50-55. PubMed ID: 29432877
[TBL] [Abstract][Full Text] [Related]
35. Vitamin D supplementation reduces insulin resistance in Japanese adults: a secondary analysis of a double-blind, randomized, placebo-controlled trial.
Sun X; Cao ZB; Tanisawa K; Ito T; Oshima S; Higuchi M
Nutr Res; 2016 Oct; 36(10):1121-1129. PubMed ID: 27865354
[TBL] [Abstract][Full Text] [Related]
36. Vitamin D and nonalcoholic fatty liver disease in children: a randomized controlled clinical trial.
El Amrousy D; Abdelhai D; Shawky D
Eur J Pediatr; 2022 Feb; 181(2):579-586. PubMed ID: 34459959
[TBL] [Abstract][Full Text] [Related]
37. Randomized controlled trial of vitamin D supplement on endothelial function in patients with type 2 diabetes.
Yiu YF; Yiu KH; Siu CW; Chan YH; Li SW; Wong LY; Lee SW; Tam S; Wong EW; Lau CP; Cheung BM; Tse HF
Atherosclerosis; 2013 Mar; 227(1):140-6. PubMed ID: 23298824
[TBL] [Abstract][Full Text] [Related]
38. Procollagen-III peptide identifies adipose tissue-associated inflammation in type 2 diabetes with or without nonalcoholic liver disease.
Barchetta I; Cimini FA; De Gioannis R; Ciccarelli G; Bertoccini L; Lenzi A; Baroni MG; Cavallo MG
Diabetes Metab Res Rev; 2018 Jul; 34(5):e2998. PubMed ID: 29471595
[TBL] [Abstract][Full Text] [Related]
39. Effect of vitamin D3 supplementation on insulin resistance and β-cell function in prediabetes: a double-blind, randomized, placebo-controlled trial.
Wallace HJ; Holmes L; Ennis CN; Cardwell CR; Woodside JV; Young IS; Bell PM; Hunter SJ; McKinley MC
Am J Clin Nutr; 2019 Nov; 110(5):1138-1147. PubMed ID: 31559433
[TBL] [Abstract][Full Text] [Related]
40. The effects of grape seed extract supplementation on cardiovascular risk factors, liver enzymes and hepatic steatosis in patients with non-alcoholic fatty liver disease: a randomised, double-blind, placebo-controlled study.
Ghanbari P; Raiesi D; Alboebadi R; Zarejavid A; Dianati M; Razmi H; Bazyar H
BMC Complement Med Ther; 2024 May; 24(1):192. PubMed ID: 38755622
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
